Profile
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Products/repevax/Repevax--2-.2023-05-09-09-31-52.jpg/jcr:content/Repevax%20(2).2023-05-09-09-31-52.jpg)
REPEVAX® is a 4-in-1 vaccine indicated for active immunisation against diphtheria, tetanus, pertussis and poliomyelitis (polio) in persons from 3 years of age as a booster following primary immunisation and for passive protection against pertussis in early infancy following maternal immunisation.
Before you prescribe this vaccine please refer to the SmPC.1
![](https://pro.campus.sanofi/.imaging/mte/portal/3840/dam/Portal/UK/Articles/ways-to-order.jpg1/jcr:content/ways-to-order.jpg)
References
- REPEVAX® Summary of Product Characteristics.
MAT-XU-2301125 (v3.0) Date of preparation: October 2023